Replies to post #192129 on Biotech Values

[jq1234]

I haven't followed old Cardio3 and newly transformed Celyad yet.

[DewDiligence]

Cellyad (CYAD.BR) selling $115M of stock (including ADRs) on unspecified terms:

http://finance.yahoo.com/news/celyad-announces-launch-proposed-global-101500562.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

CYAD -11% on financing—1.68M ordinary shares @€60.25 and 1.34M* ADRs @$68.56; the offering price of the ordinary shares (CYAD.BR) is a 4% discount to last Friday’s close:

http://finance.yahoo.com/news/celyad-raises-100-1-million-231036581.html

*Assuming exercise of underwriter’s option.

[DewDiligence]

CYAD -38% on phase-3 failure:

http://www.celyad.com/news/corporate-press-releases/celyad-announces-results-for-the-chart-1-phase-iii-clinical-trial-evaluating-c-cure-cell-therapy-1.htm?lng=en